Axxam
company
About
Axxam is focused on the development of small molecule drugs with the ability to target inflammation directly.
- 51 - 100
Highlights
Details
- Industries
- Biotechnology,Medical Device,Pharmaceutical
- Founded date
- Jan 1, 2001
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Axxam is focused on the development of small molecule drugs with the ability to target inflammation directly. The company was founded in 2011 and is based in Milan, Lombardia.
Investments
Number of Investments
Number of Lead Investments
1
0
Axxam has made 1 investments. Their most recent investment was on
Dec 14, 2016, when Acousia Therapeutics raised €2.50M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Dec 14, 2016
Acousia Therapeutics
|
Series A | €2.50M | Biotechnology | — |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
